ACUTAAS — Acutaas Chemicals Ltd.

Download Report (XLSX)
Quick Nav ACUTAAS Overview ← Screener
ACUTAAS · NSE
Acutaas Chemicals Ltd.
Healthcare NSE Equity Data: 01 Jul 2026
₹3,567.50
+₹41.26 (+1.17%)
52W High₹3,610.10
52W Low₹1,469.98
Avg Vol (20D)4.72L
RSI 1472.9
Vol Ratio0.74×
ATR 14₹139.92
5D Change+9.14%
📊 Analysis: ACUTAAS closed at ₹3,567.50 today, up 1.17%. RSI at 72.9 — in the overbought zone, price may face resistance. Price is 52.9% above its 200-day EMA (₹2,332.65) — long-term trend is up. Volume was 0.74× average — normal trading activity. Average daily range (ATR14) is ₹139.92 (3.9% of price) — useful for setting stop loss levels.
Price History — 279 trading days
Daily · NSE

Technical Conditions — 01 Jul 2026

RSI Above 70
RSI at 72.9 — statistically overbought zone
NR4 Narrow Range
Narrowest price range in 4 sessions
Near 52W High
-1.2% from 52-week high
Above EMA200
Price above 200-day EMA — long-term uptrend

Technical Indicators

Momentum
RSI (14)
72.9
Overbought zone
MACD
144.7324
Signal: 118.6973
MACD Histogram
26.0351
Bullish momentum
1D Change
+1.17%
5D Change
+9.14%
Volume Ratio
0.74×
Normal
Trend — EMA Levels
EMA 20
₹3,259.69
↑ Price above
EMA 50
₹3,002.02
↑ Price above
EMA 200
₹2,332.65
↑ Long-term uptrend
vs EMA 50
+18.84%
vs EMA 200
+52.94%
EMA Alignment
Bullish Stack
Volatility — Bollinger Bands
BB Upper
₹3,574.12
BB Mid (SMA20)
₹3,251.06
BB Lower
₹2,928.00
BB Width
0.1987
Normal width
ATR (14)
₹139.92
Daily range average
ATR % of Price
3.9%
Stop loss guide
Price Levels
52W High
₹3,610.10
At 52W high
52W Low
₹1,469.98
+142.69% above
From 52W High
-1.18%
NR7
No
Narrow range 7-day
NR4
Yes
Narrow range 4-day
Price > 20D High
No

30-Day Indicator History

Date Close RSI 1D % Vol × Conditions
01 Jul ₹3,567.50 72.9 +1.17% 0.7× RSI>70
30 Jun ₹3,526.20 71.6 -1.18% 0.7× RSI>70
29 Jun ₹3,568.20 75 +8.13% 4.5× RSI>70 MACD↑ BRK VOL
26 Jun ₹3,300.00 64.9 +0% 0.6×
25 Jun ₹3,300.00 64.9 +0.96% 0.5×
24 Jun ₹3,268.60 63.4 -0.26% 0.7×
23 Jun ₹3,277.20 64.1 +0.85% 0.7×
22 Jun ₹3,249.60 62.9 +0.1% 0.5×
19 Jun ₹3,246.20 62.7 +3.5% 0.8×
18 Jun ₹3,136.30 57.8 +4.55% 0.9×
17 Jun ₹2,999.90 50.2 +0.11% 0.6×
16 Jun ₹2,996.50 50 -3.24% 1.2×
12 Jun ₹3,145.30 59.9 +0.55% 0.8×
11 Jun ₹3,128.10 59.1 -2.46%
10 Jun ₹3,207.00 64.8 +0.26% 0.9×
09 Jun ₹3,198.70 64.5 -3.54% 0.8×
08 Jun ₹3,316.20 73.8 -0.36% 1.6× RSI>70
05 Jun ₹3,328.30 74.8 +5.17% 2.4× RSI>70 BRK VOL
04 Jun ₹3,164.70 69.4 +0.92% 0.6×
03 Jun ₹3,135.70 68.3 +3.23% 0.9×
02 Jun ₹3,037.60 64.3 +0.62%
01 Jun ₹3,018.90 63.5 -3.63% 0.7×
29 May ₹3,132.50 73 +4.4% 1.3× RSI>70
28 May ₹3,000.60 67.8 +0% 0.4×
27 May ₹3,000.60 67.8 -1.13% 0.3×
26 May ₹3,034.80 70.8 +3.8% 0.8× RSI>70
25 May ₹2,923.80 66.2 -0.93% 0.5×
22 May ₹2,951.20 68.7 -1.64% 0.5×
21 May ₹3,000.40 73.3 +4.16% 1.2× RSI>70
20 May ₹2,880.60 68.6 -0.2% 0.6×

Sector Peers — Healthcare

Symbol Price 1D % RSI Vol × EMA50
BLUEJET
Blue Jet Healthcare Ltd.
₹549.15 +4.56% 69.3 1.2× ↑ Above View →
GRANULES
Granules India Ltd.
₹811.40 -0.23% 64.9 ↑ Above View →
SYNGENE
Syngene International Ltd.
₹431.55 -1.81% 41.9 ↓ Below View →
JUBLPHARMA
Jubilant Pharmova Ltd.
₹975.90 +0.51% 51.9 ↑ Above View →
ERIS
Eris Lifesciences Ltd.
₹1,446.40 +0.9% 57 ↑ Above View →
INDGN
Indegene Ltd.
₹513.75 -2.22% 46.8 ↑ Above View →
NEULANDLAB
Neuland Laboratories Ltd.
₹18,786.00 +1.11% 74.1 0.9× ↑ Above View →
IPCALAB
Ipca Laboratories Ltd.
₹1,696.40 -0.27% 67.9 0.9× ↑ Above View →

Want to backtest a strategy on ACUTAAS?

Choose from 443 pre-built NSE strategies and see historical results in 60 seconds.

Sign Up Free →

We use cookies to keep you signed in and understand how the platform is used. See our Privacy Policy.

Still there?

Here's something you might like

or

One email a week. No spam, unsubscribe anytime.

SEBI Compliance Disclaimer

MomentumIQ is an educational platform for strategy research and backtesting. We do not provide investment advice, recommendations, or tips. All backtest results are hypothetical, based on historical data, and for educational purposes only. Past performance is not indicative of future results. Backtested results may not account for brokerage, slippage, taxes, or other real-world costs. Please consult a SEBI-registered investment advisor before making any investment decisions.